Leveraging Radiobiology for Arrhythmia Management: A New Treatment Paradigm?

Area of Science:

• Cardiology
• Radiation Oncology
• Medical Physics

Background:

• Radiation therapy is a precise, non-invasive treatment modality for solid tumors and benign diseases.
• Refractory ventricular tachycardia poses a significant clinical challenge, often requiring invasive procedures.
• Cardiac radiation therapy (CRT) is an emerging non-invasive option for managing drug-resistant ventricular tachycardia.

Purpose of the Study:

• To summarize existing clinical and preclinical literature on cardiac radiobiology.
• To discuss the implications of cardiac radiobiology for basic and translational research.
• To explore how radiobiology can inform clinical treatment paradigms for arrhythmias.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies.
• Analysis of radiobiological principles applied to cardiac tissue.
• Synthesis of findings to identify research gaps and clinical opportunities.

Main Results:

• Established evidence supports radiation therapy's efficacy and safety in various medical applications.
• Preclinical and early clinical data suggest CRT's potential in treating refractory ventricular tachycardia.
• Understanding cardiac radiobiology is crucial for optimizing CRT protocols and predicting outcomes.

Conclusions:

• Cardiac radiation therapy represents a promising non-invasive strategy for managing refractory ventricular tachycardia.
• Further research into cardiac radiobiology is essential to refine treatment protocols and expand clinical applications.
• CRT has the potential to significantly impact the management of complex cardiac arrhythmias.